FDA Inspection 1038144 — Tatyana Feldman

Tatyana Feldman — FEI 3011673859

The FDA completed an inspection of Tatyana Feldman on Jan 12, 2018 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 12, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hackensack, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.